In Los Angeles County (LAC), we implemented a cluster detection and response (CDR) social network strategy (SNS) among HIV molecular clusters with the goal of addressing service gaps and bringing individuals into HIV prevention and care, preventing further HIV transmission. SNSs have strong evidence of effectively reaching populations who may not otherwise test. The Community Health Ambassador Program (CHAP) used this strategy to distribute HIV self-test kits among the social, sexual, and behavioral networks of communities who may be at increased risk for HIV.
This global health seminar featured Dr. Dvora Joseph Davey who focused on research to address equitable delivery of HIV and STI interventions, focusing on a case study of oral and injectable PrEP, and STI management, in pregnant and lactating people, in South Africa.
This presentation examines data from 2010-2021 to discuss whether the U.S. is on track to meet the goals outlined by the EHE initiative by 2030, the data captured is looking at annual HIV infections and viral suppression rates. This presentation also expands on eight opportunities for systems change to end the HIV epidemic, including the elimination of HIV prevention and treatment inequities and the diversification of HIV scientific, clinical, and community workforce.
Presentation by Dr. Samuel Bunting that examines how patients living with mental illnesses experience disproportionately high HIV incidence and prevalence, while simultaneously experiencing numerous barriers to care. This study was conducted as mixed-methods, pilot study of psychiatrists practicing in the EHE priority jurisdictions about integrating PrEP into psychiatric care given the role as primary points of contact with the healthcare system for people with mental illnesses and HIV risk-factors. Psychiatrists practicing in high-HIV incidence areas were largely interested in prescribing PrEP but need additional training with a specific focus on practical management and integration with existing clinical workflows.
Presentation by Izzy Chiu that highlights how Trans women experience a high burden of HIV and are at high risk for hepatitis C virus (HCV). The interaction between these two diseases and the behavioral risks for HIV/HCV co-infection among trans women are understudied. The presentation shares the results of an analysis of HIV and HCV serological and behavioral data collected among trans women in San Francisco from 2019 to 2020 as part of the CDC’s first National HIV Behavioral Surveillance survey for trans women.
Oral Presentation at the CHIPTS HIV Next Generation Conference featuring Dr. Joshua A. Rusow in January 2022. The presentation examines mental health symptomology, minority stress experiences, and interpersonal violence as a potential contributing factor to HIV transmission risk behaviors over one year among sexual minority adolescence.
Oral Presentation at the CHIPTS HIV Next Generation Conference featuring Juan C. Jauregui held on January 2022. The presentation describes how gay social and sexual venues are important targets for HIV prevention engagement and how GBMSM continued to remain connected through gay geosocial networking apps throughout the pandemic. The presentation examines the impact of COVID-19 on GBMSM’s social and sexual venue attendance.
Oral presentation by Sunil Suhas Solomon at UCLA HIV Grand Rounds on June 2021. The presentation describes a research trial that examines the impact of integrated delivery of HIV prevention and treatment services in a non-discriminatory setting on uptake of HIV testing among PWID and MSM in India.
Oral presentation by Steve Shoptaw at the HPTN Annual Meeting in May 2021. The presentation provides an epidemiology understanding of intertwining epidemics of HIV and opioid use disorder in the United States. The presentation also provides an overview of HPTN 094, a study designed to reduce HIV transmission among people who inject drugs in the United States.